Early vitrectomy combined with pan retinal photocoagulation, anti-vascular endothelial growth factor, and gradual cyclophotocoagulation for treatment of neovascular glaucoma  

作　　者：Chuan Sun Hong-Song Zhang Yu-Jie Yan Tong Zhao Ai-Hong Li Yan Tang Zhi-Jun Wang 

机构地区：[1]Department of Ophthalmology,China-Japan Friendship Hospital,Beijing 100029,China

出　　处：《Chinese Medical Journal》2019年第20期2518-2520,共3页中华医学杂志（英文版）

摘　　要：To the editor: Neovascular glaucoma (NVG) is refractory glaucoma characterized by neovascularization of iris or anterior chamber angle, which often leads to dramatic elevation of intraocular pressure (IOP) and severe vision loss.[1] Series of studies have been reported regarding managing NVG with anti-vascular endothelial growth factor (VEGF) therapy or in combination with anti-glaucoma surgery.[2,3,4] However, the effect of anti-VEGF seems only temporary and it does not improve the prognosis in the long term.[5] Therefore, pan retinal photocoagulation (PRP) remains necessary for improving long term prognosis.[5] However, it is not easy to complete PRP early in NVG patients due to corneal edema, hyphema, or vitreous hemorrhage. We conducted this prospective interventional case series study to propose a protocol which could confine NVG in an early stage. The aims of our treatment modalities included that controlling IOP immediately, complete PRP as soon as possible, anti-VEGF as adjuvant and controlling residual glaucoma with gradual cyclophotocoagulation.

关 键 词：GLAUCOMA TREATMENT SURGERY 

分 类 号：R73[医药卫生—肿瘤]